Vikram Jha, 31, founder and chief executive officer of Pucho Technology Information Limited, along with his team has developed virtual drug molecules that can act as a potential drug for Covid-19. Now, the team is working to convert the virtual drug molecules into drugs by using active pharmaceutical ingredients as feedstock. According to engineers across the country, AI may hold the key to solve the Covid-19 pandemic. “The use of AI has considerably shortened the initial drug design process from several months to only a few days,” said Dr Gopalakrishnan Bulusu, principal scientist involved in producing 31 molecules for Covid drugs through AI. Kavi Arya, a professor at Indian Institute of Technology-Bombay’s computer science and engineering unit, said, “In Covid pandemic, AI may become critical in finding prospective drug molecules.

Source: Hindustan Times May 31, 2020 18:33 UTC